| Titre | Auteur | Clics |
|---|
| Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation | WFSBP | 1074 |
| Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects | WFSBP | 1006 |
| Guidelines for the treatment of adolescent sexual offenders with paraphilic disorders - 2016 | WFSBP | 1035 |
| WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry - 2010 | WFSBP | 1007 |
| Guidelines for Biological Treatment of Schizophrenia, Part 1 Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance | WFSBP | 934 |
| Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder | WFSBP | 965 |
| Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015 | WFSBP | 880 |
| Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders - 2013 | WFSBP | 856 |
| Guidelines for the pharmacological treatment of anxiety disorders, obsessive – compulsive disorder and post-traumatic stress disorder in primary care - 2012 | WFSBP | 902 |
| Guidelines for Biological Treatment of Personality Disorders - 2007 | WFSBP | 1030 |
| Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence - 2011 | WFSBP | 954 |
| Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care - 2007 | WFSBP | 993 |
| Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism - 2008 | WFSBP | 1018 |
| Guidelines for the Pharmacological Treatment of Eating Disorders - Juin 2011 | WFSBP | 974 |
| Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance | WFSBP | 1739 |
| Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder | WFSBP | 1637 |
| Pharmacological treatment of anxiety disorders | British Association for Psychopharmacology | 1845 |
| management of attention-deficit/hyperactivity disorder in adolescents in transition to adult service | British Association for Psychopharmacology | 1675 |
| Treating depressive disorders with antidepressants: a revision of the 2000 | British Association for Psychopharmacology | 1565 |
| Evidence-based Guidelines for Treating Bipolar Disorder | British Association for Psychopharmacology | 1659 |
| Evidence-based guidelines for the pharmacological treatment of schizophrenia | British Association for Psychopharmacology | 1498 |
| consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disord | British Association for Psychopharmacology | 1583 |
| Evidence based guidelines for the pharmacological management of substance abuse, harmful use, addict | British Association for Psychopharmacology | 1617 |
| Trouble panique | American Psychiatry Association | 1878 |
| Trouble obsessionnel compulsif | American Psychiatry Association | 1790 |
| Episode dépressif majeur | American Psychiatry Association | 1853 |
| Traitement pharmacologique des troubles anxieux | World Federation of Societies of Biological Psychiatry | 1824 |
| Traitement biologique de l'abus de substances et des troubles relatifs à cet abus | World Federation of Societies of Biological Psychiatry | 1973 |
| Recommandations sur les marqueurs bilogiques dans la dépression | American Psychiatry Association | 1769 |
